Hammam A. Mowafy

Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer

Alaa Eldeen B. Yassin, Md. Khalid Anwer, Hammam A. Mowafy et al. · International Journal of Medical Sciences · 2010 · 187 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Development and validation of an HPLC–UV method for the quantification of carbamazepine in rabbit plasma

Hammam A. Mowafy, Fars K. Alanazi, Gamal M. El Maghraby · Saudi Pharmaceutical Journal · 2011 · 61 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +12

Chitosan caged liposomes for improving oral bioavailability of rivaroxaban: <i>in vitro</i> and <i>in vivo</i> evaluation

Maged K. Elsayad, Hammam A. Mowafy, Alaa A. Zaky et al. · Pharmaceutical Development and Technology · 2020 · 38 citations

Pharmacy, Pharmaceutics, Pharmacokinetics +17

Validated High-Performance Liquid Chromatographic Technique for Determination of 5-Fluorouracil: Applications to Stability Studies and Simulated Colonic Media

Fars K. Alanazi, Alaa Eldeen B. Yassin, Mahmoud El‐Badry et al. · Journal of Chromatographic Science · 2009 · 32 citations · Full text

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

Comparative study of itraconazole-cyclodextrin inclusion complex and its commercial product

Ibrahim A. Alsarra, Fars K. Alanazi, Sayed M. Ahmed et al. · Archives of Pharmacal Research · 2010 · 18 citations

Pharmacy, Chemistry, Pharmaceutics +10